Drug:
Reaction: ECZEMA
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26905612 |
US |
2 | |
Conjunctivitis, Blepharitis, Dry eye, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 202 | 26905617 |
US |
7 | 2 |
Illness, Feeling hot, Sleep disorder due to a general medical condition, Respiratory tract congestion, Pruritus, Eczema, Rash, |
||||
DUPILUMAB, ALBUTEROL SULFATE, PIMECROLIMUS, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 203 | 26905621 |
US |
7 | 1 |
Eczema, Erythema, Pruritus, Therapeutic response shortened, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 204 | 26905623 |
US |
21 | 1 |
Eczema, Pruritus, Dry skin, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 205 | 26905643 |
US |
1 | 1 |
Eczema, Dry skin, Off label use, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 206 | 26905661 |
US |
22 | 2 |
Eczema, Dermatitis allergic, |
||||
DUPILUMAB, |
||||
| 207 | 26905662 |
US |
55 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 208 | 26905989 |
US |
68 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 209 | 26906011 |
US |
14 | 2 |
Eczema, Rash, |
||||
DUPILUMAB, |
||||
| 210 | 26906032 |
US |
25 | 2 |
Dry eye, Eczema, Pruritus, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 211 | 26906679 |
US |
15 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 212 | 26906695 |
US |
65 | 2 |
Eye discharge, Ocular hyperaemia, Eczema, Rash, Eye pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 213 | 26906710 |
US |
59 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 214 | 26906939 |
JP |
2 | |
Infection, Asthma, Eczema, Off label use, |
||||
TOCILIZUMAB, |
||||
| 215 | 26907045 |
US |
72 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 216 | 26907046 |
US |
2 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 217 | 26907072 |
US |
6 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 218 | 26907073 |
US |
87 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 219 | 26907170 |
US |
10 | 2 |
Pruritus, Eczema, |
||||
DUPILUMAB, |
||||
| 220 | 26907541 |
US |
46 | 1 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 221 | 26907809 |
70 | ||
Eczema, |
||||
LENIOLISIB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
| 222 | 26907863 |
US |
29 | 2 |
Injection site vesicles, Pruritus, Skin exfoliation, Eczema, |
||||
DUPILUMAB, |
||||
| 223 | 26908148 |
US |
69 | 2 |
Eczema, Pruritus, Pain, Paraesthesia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 224 | 26908594 |
US |
12 | 2 |
Eczema, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 225 | 26908816 |
US |
55 | 1 |
Heart rate increased, Rash erythematous, Blister, Eczema, |
||||
DUPILUMAB, |
||||
| 226 | 26908984 |
US |
20 | 1 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 227 | 26909304 |
US |
25 | 2 |
Influenza, Pyrexia, Eczema, Pruritus, Dry skin, Asthma, |
||||
DUPILUMAB, DUPILUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, LEVOCETIRIZINE DIHYDROCHLORIDE, ROFLUMILAST, |
||||
| 228 | 26909333 |
US |
2 | |
Eczema, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 229 | 26912817 |
2 | ||
Eczema, Fatigue, |
||||
TEPOTINIB HYDROCHLORIDE, LOSARTAN, |
||||
| 230 | 26903657 |
US |
2 | |
Eczema, Pruritus, Haemorrhage, Skin weeping, Dry skin, Scab, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, CETIRIZINE HCL, CETIRIZINE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MOMETASONE FUROATE, MOMETASONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 231 | 26903682 |
US |
3 | 2 |
Eczema, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 232 | 26903683 |
US |
7 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 233 | 26903684 |
US |
14 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 234 | 26903783 |
US |
70 | 1 |
Sleep apnoea syndrome, Eczema, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 235 | 26903785 |
US |
59 | 1 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 236 | 26903828 |
US |
27 | 2 |
Eczema, Paraesthesia, Skin tightness, Erythema, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 237 | 26903830 |
US |
43 | 2 |
Visual impairment, Eczema, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 238 | 26903878 |
US |
2 | 1 |
Eczema, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 239 | 26903883 |
US |
1 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 240 | 26903889 |
US |
72 | 1 |
Eczema, Skin fissures, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 241 | 26903912 |
US |
1 | |
Eczema, Drug ineffective, |
||||
DUPILUMAB, TRALOKINUMAB-LDRM, ALBUTEROL SULFATE, OCTOCRYLENE, AVOBENZONE, DUTASTERIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 242 | 26903961 |
US |
89 | 2 |
Eczema, Rash pruritic, Product use in unapproved indication, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, POLYETHYLENE GLYCOL 3350, ESCITALOPRAM OXALATE, ESCITALOPRAM, ERGOCALCIFEROL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 243 | 26903981 |
US |
72 | |
Eczema, |
||||
DUPILUMAB, |
||||
| 244 | 26904024 |
US |
38 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 245 | 26904026 |
US |
61 | 2 |
Eczema, Pruritus, Dry skin, Injection site bruising, Skin discolouration, Rash pruritic, Pain, Rash, |
||||
DUPILUMAB, |
||||
| 246 | 26904051 |
US |
33 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 247 | 26904068 |
US |
71 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 248 | 26904273 |
US |
2 | 1 |
Pruritus, Eczema, |
||||
DUPILUMAB, |
||||
| 249 | 26904292 |
US |
1 | |
Eczema, |
||||
DUPILUMAB, FISH OIL, |
||||
| 250 | 26904499 |
JP |
79 | 1 |
Hospitalisation, Eczema, |
||||
APALUTAMIDE, |
||||
| 251 | 26902733 |
US |
69 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 252 | 26902766 |
US |
76 | 1 |
Pruritus, Eczema, |
||||
DUPILUMAB, |
||||
| 253 | 26902826 |
US |
28 | 2 |
Eczema, Dry skin, Pruritus, Erythema, Pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 254 | 26902836 |
US |
18 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 255 | 26902846 |
US |
10 | 2 |
Mood altered, Sleep disorder due to a general medical condition, Eczema, Erythema, Skin swelling, Rash pruritic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 256 | 26902908 |
US |
73 | 1 |
Dry skin, Skin exfoliation, Pruritus, Eczema, |
||||
DUPILUMAB, |
||||
| 257 | 26902914 |
US |
49 | 1 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 258 | 26902930 |
US |
5 | 2 |
Eczema, Pain, Burning sensation, |
||||
DUPILUMAB, |
||||
| 259 | 26902945 |
US |
58 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 260 | 26902972 |
US |
72 | 2 |
Eye irritation, Eczema, Rash erythematous, Rash pruritic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 261 | 26903019 |
US |
26 | 1 |
Pruritus, Eczema, |
||||
DUPILUMAB, |
||||
| 262 | 26903054 |
US |
8 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 263 | 26903059 |
US |
14 | 2 |
Eczema, Eyelid skin dryness, Eyelids pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 264 | 26903070 |
US |
1 | |
Eczema, Hip surgery, |
||||
DUPILUMAB, |
||||
| 265 | 26903169 |
US |
28 | 2 |
Eczema, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 266 | 26903350 |
CL |
71 | 1 |
Septic shock, Gastrointestinal disorder, Septic vasculitis, Streptococcal infection, Eczema, Neurodermatitis, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISONE, |
||||
| 267 | 26897571 |
US |
2 | |
Eczema, Inappropriate schedule of product administration, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 268 | 26897618 |
US |
71 | 2 |
Surgery, Eczema, |
||||
RISANKIZUMAB-RZAA, |
||||
| 269 | 26897722 |
US |
49 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 270 | 26897731 |
US |
39 | 2 |
Eczema, Rash, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 271 | 26897935 |
US |
1 | |
Eczema, Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 272 | 26897958 |
US |
2 | |
Eczema, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, CLONAZEPAM, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, HYDROCHLOROTHIAZIDE, LISINOPRIL, MOMETASONE FUROATE, MOMETASONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, |
||||
| 273 | 26898189 |
US |
2 | |
Eczema, Acne, Skin weeping, Skin haemorrhage, |
||||
DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MOMETASONE FUROATE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ERGOCALCIFEROL, FLUTICASONE PROPIONATE AND SALMETEROL, LEVALBUTEROL TARTRATE, |
||||
| 274 | 26898236 |
US |
1 | |
Eczema, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 275 | 26898355 |
US |
57 | |
Eczema, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 276 | 26898438 |
US |
3 | 2 |
Pruritus, Eczema, Skin fissures, Injection site pain, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 277 | 26898462 |
US |
68 | 2 |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 278 | 26898698 |
US |
2 | |
Hyperhidrosis, Eczema, |
||||
DUPILUMAB, |
||||
| 279 | 26898722 |
US |
64 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 280 | 26898725 |
US |
2 | |
Eczema, |
||||
DUPILUMAB, DUPILUMAB, FAMOTIDINE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, IRON, LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, NALTREXONE HYDROCHLORIDE, VITAMIN C, BUPROPION HYDROCHLORIDE, |
||||
| 281 | 26899091 |
CA |
32 | 2 |
Pneumonia, Nasal congestion, Infection, Sinusitis, Sleep disorder due to a general medical condition, Vertigo, Urticaria, Vomiting, Rhinitis, Therapeutic product effect decreased, Nasopharyngitis, Decreased activity, Oropharyngeal pain, Stress, Dyspnoea exertional, Eczema, Feeding disorder, Psoriasis, Dizziness, Full blood count abnormal, Pain, Cough, Diarrhoea, Influenza, Tooth abscess, Ear infection, Drug ineffective, Product administration error, Asthma, Middle insomnia, Abdominal pain, Loss of personal independence in daily activities, Upper-airway cough syndrome, Wheezing, Productive cough, Migraine, Therapeutic response decreased, Blood pressure increased, Eosinophil count abnormal, Bacterial infection, Terminal insomnia, Dyspnoea, Anxiety, Fungal infection, Urinary tract infection, Musculoskeletal chest pain, Restrictive pulmonary disease, Nasal discharge discolouration, Emphysema, Forced expiratory volume decreased, Rales, Malaise, Tachycardia, Heart rate increased, Sleep disorder, Obstructive airways disorder, |
||||
FLUTICASONE PROPIONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IPRATROPIUM BROMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MEPOLIZUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMALIZUMAB, |
||||
| 282 | 26899377 |
EU |
66 | 1 |
Eczema, |
||||
| 283 | 26899551 |
US |
17 | 2 |
Eczema, Loss of personal independence in daily activities, Mood altered, |
||||
TRALOKINUMAB-LDRM, |
||||
| 284 | 26900032 |
US |
29 | 2 |
Eczema, Pruritus, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 285 | 26900041 |
US |
11 | 2 |
Nasopharyngitis, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 286 | 26900815 |
US |
0 | 2 |
Psoriasis, Eczema, |
||||
PROPRANOLOL HYDROCHLORIDE, |
||||
| 287 | 26901855 |
US |
45 | 1 |
Eczema, Product dose omission issue, |
||||
BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, |
||||
| 288 | 26902128 |
US |
28 | 2 |
Eczema, Urticaria, Skin swelling, Pain of skin, Skin discomfort, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, LORAZEPAM, |
||||
| 289 | 26902507 |
US |
18 | 1 |
Eczema, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 290 | 26902537 |
US |
51 | 1 |
Injection site pain, Eczema, Pruritus, Rebound effect, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 291 | 26902613 |
US |
2 | 2 |
Eczema, Incorrect dose administered, Off label use, Product storage error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 292 | 26891902 |
US |
48 | 2 |
Eczema, Pruritus, |
||||
DUPILUMAB, |
||||
| 293 | 26892048 |
US |
59 | 1 |
Cellulitis, Eczema, Injection site papule, Device issue, Injection site pain, Fatigue, Device physical property issue, Artificial crown procedure, Peripheral swelling, Musculoskeletal disorder, Pyrexia, Hypotension, Staphylococcal infection, Impaired healing, Immune system disorder, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 294 | 26892072 |
US |
67 | 1 |
Eczema, |
||||
DUPILUMAB, |
||||
| 295 | 26892073 |
US |
34 | 1 |
Eczema, Erythema, Periorbital swelling, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 296 | 26892241 |
US |
12 | 2 |
Eczema, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 297 | 26892293 |
US |
79 | 2 |
Eczema, |
||||
DUPILUMAB, |
||||
| 298 | 26892572 |
US |
63 | 1 |
Eczema, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 299 | 26892805 |
US |
13 | 2 |
Eczema, Off label use, |
||||
DUPILUMAB, |
||||
| 300 | 26892814 |
US |
15 | 2 |
Eczema, Product dose omission issue, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30